Jackson Square Capital LLC Makes New $3.36 Million Investment in Agilent Technologies, Inc. $A

Posted by Brenda Bartman on Oct 19th, 2026

Jackson Square Capital LLC purchased a new position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) during the 3rd quarter, Holdings Channel.com reports. The fund purchased 19,515 shares of the medical research company’s stock, valued at approximately $3,363,000.

A number of other large investors have also recently added to or reduced their stakes in A. Kaufman Rossin Wealth LLC acquired a new stake in Agilent Technologies in the 3rd quarter valued at about $206,000. Frank Rimerman Advisors LLC acquired a new position in Agilent Technologies during the third quarter worth approximately $213,000. Fiscal Wisdom Wealth Management LLC acquired a new position in Agilent Technologies during the third quarter worth approximately $225,000. Counterpoint Mutual Funds LLC raised its stake in Agilent Technologies by 94.4% in the third quarter. Counterpoint Mutual Funds LLC now owns 5,033 shares of the medical research company’s stock valued at $867,000 after buying an additional 2,444 shares during the period. Finally, Copper Harbor Investment Advisors LLC bought a new stake in Agilent Technologies in the third quarter valued at approximately $233,000.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock traded down $1.62 on Monday, hitting $171.35. The stock had a trading volume of 577,937 shares, compared to its average volume of 2,260,049. The stock has a market cap of $48.31 billion, a price-to-earnings ratio of 33.73, a price-to-earnings-growth ratio of 2.63 and a beta of 1.21. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $177.47. The business’s 50 day moving average is $159.00 and its two-hundred day moving average is $137.72.

Agilent Technologies (NYSE:A – Get Free Report) last released its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.13. The business had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The firm’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same period last year, the firm posted $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Analysts forecast that Agilent Technologies, Inc. will post 6.20 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 28th. Stockholders of record on Tuesday, October 6th will be issued a dividend of $0.2550 per share. The ex-dividend date of this dividend is Tuesday, October 6th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.6%. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.08%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. Morgan Stanley raised their price objective on Agilent Technologies from $175.00 to $190.00 and gave the company an “overweight” rating in a research report on Tuesday, October 13th. Bank of America boosted their target price on Agilent Technologies from $155.00 to $180.00 and gave the stock a “buy” rating in a report on Thursday, August 27th. Sanford C. Bernstein increased their price target on Agilent Technologies from $155.00 to $180.00 and gave the company an “outperform” rating in a research note on Thursday, August 27th. Weiss Ratings raised Agilent Technologies from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Finally, Citigroup lifted their price objective on shares of Agilent Technologies from $185.00 to $190.00 and gave the stock a “buy” rating in a research report on Thursday, August 27th. Fifteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $173.65.

Check Out Our Latest Report on A

Insider Buying and Selling at Agilent Technologies

In other news, Director Mikael Dolsten sold 634 shares of the business’s stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the completion of the sale, the director owned 4,924 shares of the company’s stock, valued at approximately $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

Agilent Technologies Profile

(Free Report)

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.